Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,168 | Dovepress* | 7,155+ | 959 | 8,114 | |
| PubMed Central* | 1,013 | 332 | 1,345 | ||
| Totals | 8,168 | 1,291 | 9,459 | ||
| *Since 14 November 2017 | |||||
View citations on PubMed Central and Google Scholar